ISSN NO. 2320 - 7418
A RARE CASE OF THALASSEMIA INTERMEDIA WITH MULTIPLE ALLOANTIBODIES
DR DIBYAJYOTI SAHOO, DR SMITA MAHAPATRA, DR RAJIV KUMAR NAYAK, DR DEBASISH MISHRA
Presence of anti red cell antibodies remains a major problem in Thalassemia patients. Beta-Thalassemia major patients do commonly suffer from alloimmunization which is rarely seen in Thalassemia intermedia patients. Association of multiple antibodies and antibody against high frequency blood group antigen further complicates the transfusion therapy. Advance immunohematological tests like adsorption, elution, and phenotyping are necessary along with antibody typing and identification. The present case is a 24 year male Thalassemia intermedia patient, whose blood sample when cross matched found incompatible with more than 100 units of PRBC. Various tests like DCT, ICT, 3 cell panel, 4 cell panel, 10, 11, 16 cell panels, adsorption, elution, minor phenotyping were done to resolve the case. We found multiple alloantibodies with no autoantibody. The present case emphasises on importance of minor phenotyping before first transfusion in all multitransfused patients, and importance of immunohematological tests in resolving blood incompatibility.
Keywords: Alloimmunization, phenotyping, adsorption, elution
Full Text Article
Call of Papers
Submit Article for Vol. 8 Issue 1 January 2019
Publish : 31-Jan-2019
JMPAS is DOI (digital object identifier) and International plagarism clearance certified
Dear Author/Researcher, Journal of Medical Pharmaceuticals and Allied Sciences (JMPAS) invites you to submit your research paper for publishing in Volume 8, Issue 1 (January 2019). Scope & Topics: Journal of Medical Pharmaceuticals and Allied Sciences (JMPAS) is a open access journal that publishes articles which contribute best results in all areas of the Medical, Pharmaceuticals and Allied Sciences.
Forthcoming issue will publish on 31/01/2019